Get it on Google Play

Sputnik V Vaccine : Approved For Emergency Use In India

Sputnik V:

Russia’s COVID-19 vaccine — Sputnik V — has been recommended for emergency use authorization in India following a meeting of the Subject Expert Committee (SEC).

  • If approved by the Drug Controller General of India (DCGI), Sputnik V would be the third vaccine to be made available in India after the Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.
  • Sputnik V, developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, claims to be one of the three vaccines in the world with an efficacy of over 90%.
  • the vaccine supplies for the global market will be produced by the Russian Direct Investment Fund (RDIF) international partners in India, Brazil, China, South Korea, and other countries.

Leave a Reply

Your email address will not be published. Required fields are marked *